Page last updated: 2024-10-23

5-methoxypsoralen and Cataract

5-methoxypsoralen has been researched along with Cataract in 2 studies

5-Methoxypsoralen: A linear furanocoumarin that has phototoxic and anti-inflammatory properties, with effects similar to METHOXSALEN. It is used in PUVA THERAPY for the treatment of PSORIASIS.
5-methoxypsoralen : A 5-methoxyfurocoumarin that is psoralen substituted by a methoxy group at position 5.

Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barker, FM1
Dayhaw-Barker, P1
Forbes, PD1
Davies, RE1

Other Studies

2 other studies available for 5-methoxypsoralen and Cataract

ArticleYear
British Photodermatology Group guidelines for PUVA.
    The British journal of dermatology, 1994, Volume: 130, Issue:2

    Topics: 5-Methoxypsoralen; Cataract; Dermatitis, Atopic; Humans; Methoxsalen; Mycosis Fungoides; Psoriasis;

1994
Ocular effects of treatment with various psoralen derivatives and ultraviolet-A (UVA) radiation in HRA/Skh hairless mice.
    Acta ophthalmologica, 1986, Volume: 64, Issue:4

    Topics: 5-Methoxypsoralen; Animals; Cataract; Corneal Opacity; Eye; Furocoumarins; Methoxsalen; Mice; Mice,

1986